In this issue:
Sepsis and risk of health conditions in adulthood
Long-term response of dasatinib and blinatumomab
Safety and efficacy of oral decitabine plus cedazuridine and venetoclax
High-dose chemotherapy and ASCT
Analysis of new first-line therapy regimen
Comparison of SOC and axi-cel
Brentuximab with dacarbazine or nivolumab
Validating the EWALL-PI
Progression after ICIs
PS in R/R AML patients
Please login below to download this issue (PDF)